Giovanni Assenza Selected Research

Giovanni Assenza Research Topics

Disease

14	Epilepsy (Aura) 11/2022 - 01/2014
9	Seizures (Absence Seizure) 02/2024 - 05/2013
7	Partial Epilepsies (Epilepsy, Partial) 05/2024 - 05/2012
5	Drug Resistant Epilepsy 05/2024 - 01/2014
5	Temporal Lobe Epilepsy 11/2022 - 02/2017
4	Stroke (Strokes) 01/2018 - 02/2009
3	Transient Global Amnesia 11/2022 - 11/2018
3	Amnesia (Dissociative Amnesia) 11/2022 - 11/2018
3	Myoclonus (Nocturnal Myoclonus) 01/2021 - 02/2017
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021 - 01/2017
2	Unverricht-Lundborg Syndrome (Disease, Unverricht) 01/2021 - 01/2017
2	COVID-19 01/2021 - 08/2020
1	Focal Cortical Dysplasia 01/2023
1	Disease Progression 04/2021
1	Cognitive Dysfunction 04/2021
1	Mucolipidoses (Sialidosis) 01/2021
1	Lafora Disease 01/2021
1	Treatment-Resistant Depressive Disorder 11/2020
1	Brain Diseases (Brain Disorder) 10/2020
1	Sleep Wake Disorders 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Intellectual Disability (Idiocy) 07/2019
1	Epilepsia Partialis Continua 01/2019
1	Language Disorders (Language Disorder) 11/2018
1	Confusion (Bewilderment) 11/2018
1	Vitamin D Deficiency 05/2018
1	Ischemic Stroke 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Cerebellar Ataxia (Dysmetria) 01/2016
1	Muscle Weakness 09/2014
1	Hyperhidrosis 09/2014
1	Muscular Diseases (Myopathy) 11/2013
1	Dementia (Dementias) 05/2013
1	Parkinson Disease (Parkinson's Disease) 05/2013

Drug/Important Bio-Agent (IBA)

8	Anticonvulsants (Antiepileptic Drugs)IBA 04/2021 - 11/2013
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
3	TeaIBA 11/2022 - 11/2018
3	Levetiracetam (Keppra)FDA LinkGeneric 11/2022 - 01/2021
3	perampanelIBA 01/2021 - 01/2021
3	salicylhydroxamic acid (SHAM)IBA 03/2017 - 05/2012
2	bis(tri- n- hexylsiloxy)(2,3- naphthalocyaninato)silicon (SINC)IBA 09/2020 - 08/2020
2	eslicarbazepine acetateIBA 07/2019 - 01/2018
2	CopperIBA 01/2018 - 02/2009
2	Transferrin (beta 2 Transferrin)IBA 01/2018 - 02/2009
2	PeroxidesIBA 01/2018 - 02/2009
2	IronIBA 01/2018 - 02/2009
2	AntioxidantsIBA 01/2018 - 02/2009
2	Ceruloplasmin (Ferroxidase)IBA 01/2018 - 02/2009
1	brivaracetamIBA 05/2024
1	CenobamateIBA 02/2024
1	Calcifediol (Calcidiol)FDA Link 01/2023
1	Complement System Proteins (Complement)IBA 04/2021
1	Amyloid (Amyloid Fibrils)IBA 04/2021
1	Familial apoceruloplasmin deficiencyIBA 01/2021
1	mesoglycanIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 11/2020
1	Metronidazole (Metric)FDA LinkGeneric 10/2020
1	Myelin-Associated GlycoproteinIBA 01/2020
1	erucylphosphocholineIBA 01/2019
1	CalciumIBA 05/2018
1	hydroxide ionIBA 05/2018
1	Vitamin D FDA LinkGeneric 05/2018
1	Ferritins (Ferritin)IBA 01/2018
1	MetalsIBA 01/2018
1	Lamotrigine (Lamictal)FDA LinkGeneric 02/2017
1	Cystatin BIBA 01/2017
1	PlasticsIBA 01/2016
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Nerve Growth Factors (Neurotrophins)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2014
1	Zonisamide (Zonegran)FDA LinkGeneric 05/2013
1	ZincIBA 02/2009

Therapy/Procedure

7	Therapeutics 05/2024 - 01/2016
3	Transcranial Direct Current Stimulation 01/2018 - 01/2014
2	Vagus Nerve Stimulation 01/2021 - 11/2020
1	Palliative Care (Palliative Therapy) 11/2020
1	Protective Devices (Safety Device) 08/2020
1	Stroke Rehabilitation 10/2014
1	Neurological Rehabilitation 10/2014
1	Transcranial Magnetic Stimulation 05/2013